Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioEnterprise ValueInventory AverageInvested Capital

Mesoblast (MESO) EBITDA Margin (2016 - 2023)

Historic EBITDA Margin for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to 139089.06%.

  • Mesoblast's EBITDA Margin rose 57957100.0% to 139089.06% in Q2 2023 from the same period last year, while for Jun 2023 it was 8913.69%, marking a year-over-year increase of 87919100.0%. This contributed to the annual value of 360.79% for FY2025, which is 6353800.0% up from last year.
  • Latest data reveals that Mesoblast reported EBITDA Margin of 139089.06% as of Q2 2023, which was up 57957100.0% from 60282.57% recorded in Q1 2023.
  • In the past 5 years, Mesoblast's EBITDA Margin registered a high of 353505.73% during Q2 2021, and its lowest value of 81291.64% during Q1 2021.
  • In the last 5 years, Mesoblast's EBITDA Margin had a median value of 14163.98% in 2020 and averaged 27998.87%.
  • As far as peak fluctuations go, Mesoblast's EBITDA Margin soared by 2000000000bps in 2020, and later tumbled by 2000000000bps in 2022.
  • Mesoblast's EBITDA Margin (Quarter) stood at 33300.91% in 2019, then soared by 101bps to 447.52% in 2020, then plummeted by -9274bps to 41057.28% in 2021, then grew by 5bps to 38887.07% in 2022, then skyrocketed by 458bps to 139089.06% in 2023.
  • Its EBITDA Margin stands at 139089.06% for Q2 2023, versus 60282.57% for Q1 2023 and 38887.07% for Q4 2022.